Syrian hamster tumor model to study oncolytic ad5-based vectors

Methods in Molecular Biology

Volumn 797, Issue , 2012, Pages 53-63

  Dhar, Debanjan ^a   Toth, Karoly ^a   Wold, William S M ^b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer gene therapy; Immunosuppression; Intraperitoneal tumors; Neutralization; Oncolytic adenovirus vector; Syrian hamster model

Indexed keywords

ADENOVIRUS; ANIMAL; ARTICLE; EXPERIMENTAL NEOPLASM; GENE VECTOR; GENETICS; HAMSTER; HUMAN; METHODOLOGY; ONCOLYTIC VIROTHERAPY; SYRIAN HAMSTER; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CRICETINAE; GENETIC VECTORS; HUMANS; MESOCRICETUS; NEOPLASMS, EXPERIMENTAL; ONCOLYTIC VIROTHERAPY; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; MESOCRICETUS AURATUS;

EID: 80555127437     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-340-0_4     Document Type: Chapter

References (15)

1. Thomas, M. A., Spencer, J. F., La Regina, M. C., Dhar, D., Tollefson, A. E., Toth, K., et al. (2006) Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. Cancer Res. 66, 1270–6
2. Dhar, D., Spencer, J. F., Toth, K., and Wold, W. S. (2009) Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamsters. J. Virol. 83, 2130–9
3. Dhar, D., Spencer, J. F., Toth, K., and Wold, W. S. (2009) Pre-existing Immunity and Passive Immunity to Adenovirus 5 Prevents Toxicity Caused by an Oncolytic Adenovirus Vector in the Syrian Hamster Model. Mol. Ther. 17, 1724–32
4. Lichtenstein, D. L., Spencer, J. F., Doronin, K., Patra, D., Meyer, J. M., Shashkova, E. V., et al. (2009) An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector. Cancer Gene Ther. 16, 644–54
5. Ying, B., Toth, K., Spencer, J. F., Meyer, J., Tollefson, A. E., Patra, D., et al. (2009) INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies. Cancer Gene Ther. 16, 625–37
6. Spencer, J. F., Sagartz, J. E., Wold, W. S. M., and Toth, K. (2009) New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster. Cancer Gene Ther. 16, 912–22
7. Thomas, M. A., Spencer, J. F., Toth, K., Sagartz, J. E., Phillips, N. J., and Wold, W. S. (2008) Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model. Mol. Ther. 16, 1665–73
8. Toth, K., Spencer, J. F., Dhar, D., Sagartz, J. E., Buller, R. M., Painter, G. R., et al. (2008) Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc. Natl. Acad. Sci.USA 105, 7293–7
9. Bortolanza, S., Alzuguren, P., Bunuales, M., Qian, C., Prieto, J., and Hernandez-Alcoceba, R. (2007) Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters. Hum. Gene Ther. 18, 681–90
10. Bortolanza, S., Bunuales, M., Otano, I., Gonzalez-Aseguinolaza, G., Ortiz-de-Solorzano, C., Perez, D., et al. (2009) Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters. Mol. Ther. 17, 614–22
11. Bortolanza, S., Bunuales, M., Alzuguren, P., Lamas, O., Aldabe, R., Prieto, J., et al. (2009) Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters. Cancer Gene Ther. 16, 703–12
12. Matthews, K., Noker, P. E., Tian, B., Grimes, S. D., Fulton, R., Schweikart, K., et al. (2009) Identifying the safety profile of Ad5.SSTR/ TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer. Clin. Cancer Res. 15, 4131–7
13. Thomas, M. A., Spencer, J. F., and Wold, W. S. (2007) Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors. Methods Mol. Med. 130, 169–83
14. Tollefson, A. E., Kuppuswamy, M., Shashkova, E. V., Doronin, K., and Wold, W. S. (2007) Preparation and titration of CsCl-banded adenovirus stocks. Methods Mol. Med. 130, 223–35
15. Tollefson, A. E., Hermiston, T. W., and Wold, W. S. M. (1998) Preparation and titration of CsCl-banded adenovirus stocks. 21, 1–9